Complementary Selectivity for Peptide Analysis

Guest Author: Dr. Jeff Layne It seems like more and more companies are shifting their focus towards the development of biopharmaceuticals these days.  Peptide analysis, whether it be intact therapeutic Continue Reading

ADCs-Magic Bullets, Failed Drugs, and Heterobifunctional Linkers

ADCs

Guest Author: Brian Rivera, Product Manager: Bio Separations Over a hundred years ago, Nobel Prize laureate, Paul Ehrlich, envisioned a drug which could kill microbes but not harm the body, Continue Reading